IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
21.37
-0.92 (-4.13%)
At close: Jun 27, 2025, 4:00 PM
21.31
-0.06 (-0.28%)
After-hours: Jun 27, 2025, 7:29 PM EDT
IDEAYA Biosciences Stock Forecast
Stock Price Forecast
The 13 analysts that cover IDEAYA Biosciences stock have a consensus rating of "Strong Buy" and an average price target of $53.42, which forecasts a 149.98% increase in the stock price over the next year. The lowest target is $27 and the highest is $68.
Price Target: $53.42 (+149.98%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for IDEAYA Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 4 | 4 |
| Buy | 7 | 7 | 7 | 7 | 7 | 8 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Initiates $44 | Buy | Initiates | $44 | +105.90% | Jun 26, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $63 → $66 | Buy | Maintains | $63 → $66 | +208.84% | May 22, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $50 | Buy | Reiterates | $50 | +133.97% | Feb 14, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $61 | Buy | Reiterates | $61 | +185.45% | Jan 15, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jan 13, 2025 |
Financial Forecast
Revenue This Year
14.08M
from 7.00M
Increased by 101.20%
Revenue Next Year
54.46M
from 14.08M
Increased by 286.70%
EPS This Year
-3.27
from -3.36
EPS Next Year
-3.08
from -3.27
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 35.9M | 183.2M | 225.2M | ||
| Avg | 14.1M | 54.5M | 157.4M | ||
| Low | n/a | 6.0M | 101.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 413.0% | 1,200.7% | 313.6% | ||
| Avg | 101.2% | 286.7% | 189.1% | ||
| Low | - | -57.6% | 85.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -2.75 | -2.22 | -1.67 | ||
| Avg | -3.27 | -3.08 | -2.64 | ||
| Low | -3.62 | -4.00 | -3.74 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.